{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:10:28Z","timestamp":1777392628357,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T00:00:00Z","timestamp":1543708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2018HXBH005"],"award-info":[{"award-number":["2018HXBH005"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.biopha.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T06:10:24Z","timestamp":1544422224000},"page":"641-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Insight into the role of TRAIL in liver diseases"],"prefix":"10.1016","volume":"110","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao-You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.biopha.2018.12.004_bib0020","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of Apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family","volume":"271","author":"Pitti","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02592977","article-title":"Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily","volume":"26","author":"Gruss","year":"1996","journal-title":"Int. J. Clin. Lab. Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1016-8478(23)13739-3","article-title":"TRAIL, a mighty apoptosis inducer","volume":"15","author":"Kim","year":"2003","journal-title":"Mol. Cells"},{"issue":"8","key":"10.1016\/j.biopha.2018.12.004_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrurol.2011.81","article-title":"TRAIL-mediated signaling in prostate, bladder and renal cancer","volume":"8","author":"Voelkel-Johnson","year":"2011","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0040","first-page":"332","article-title":"Journey of TRAIL from bench to bedside and its potential role in immuno-oncology","volume":"11","author":"Naoum","year":"2017","journal-title":"Oncol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/CAD.0000000000000163","article-title":"2\u2019-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells","volume":"26","author":"Ismail","year":"2015","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.1016\/j.biopha.2018.12.004_bib0050","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/14935","article-title":"Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation","volume":"6","author":"Mongkolsapaya","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.biopha.2018.12.004_bib0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2009.04905.x","article-title":"TRAIL-induced apoptosis: between tumor therapy and immunopathology","volume":"1171","author":"Corazza","year":"2009","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2018.12.004_bib0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.biopha.2017.12.082","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies","volume":"98","author":"Naimi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.12.004_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-1119(97)00509-X","article-title":"Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells","volume":"204","author":"Tan","year":"1997","journal-title":"Gene"},{"issue":"30","key":"10.1016\/j.biopha.2018.12.004_bib0080","doi-asserted-by":"crossref","first-page":"23319","DOI":"10.1074\/jbc.M910438199","article-title":"Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor","volume":"275","author":"Truneh","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.biopha.2018.12.004_bib0085","doi-asserted-by":"crossref","first-page":"25065","DOI":"10.1074\/jbc.C000284200","article-title":"FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts","volume":"275","author":"Kuang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1074-7613(00)80211-3","article-title":"FADD\/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2","volume":"12","author":"Sprick","year":"2000","journal-title":"Immunity"},{"issue":"25","key":"10.1016\/j.biopha.2018.12.004_bib0095","doi-asserted-by":"crossref","first-page":"22320","DOI":"10.1074\/jbc.M202458200","article-title":"An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.biopha.2018.12.004_bib0100","doi-asserted-by":"crossref","first-page":"25020","DOI":"10.1074\/jbc.M202946200","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED\/PEA-15 in glioma cells","volume":"277","author":"Xiao","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cellsig.2014.11.014","article-title":"TRAIL activates JNK and NF-kappaB through RIP1-dependent and -independent pathways","volume":"27","author":"Zhang","year":"2015","journal-title":"Cell Signal."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/35070096","article-title":"Regulation of death receptor expression and TRAIL\/Apo2L-induced apoptosis by NF-kappaB","volume":"3","author":"Ravi","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0115","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.171.3.1526","article-title":"TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells","volume":"171","author":"Li","year":"2003","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1096\/fj.10-170480","article-title":"The role of TRADD in TRAIL-induced apoptosis and signaling","volume":"25","author":"Cao","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2018.12.004_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fimmu.2018.00015","article-title":"TRAIL-mediated suppression of T cell receptor signaling inhibits T cell activation and inflammation in experimental autoimmune encephalomyelitis","volume":"9","author":"Chyuan","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1369\/jhc.3A6112.2004","article-title":"Tissue distribution of the death ligand TRAIL and its receptors","volume":"52","author":"Spierings","year":"2004","journal-title":"J. Histochem. Cytochem."},{"issue":"11","key":"10.1016\/j.biopha.2018.12.004_bib0135","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3748\/wjg.v9.i11.2433","article-title":"Expression of TNF-related apoptosis-inducing ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma","volume":"9","author":"Chen","year":"2003","journal-title":"World J. Gastroenterol."},{"issue":"21","key":"10.1016\/j.biopha.2018.12.004_bib0140","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/1078-0432.CCR-09-3389","article-title":"Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3","volume":"16","author":"Chen","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bcp.2011.12.035","article-title":"Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3","volume":"83","author":"Chen","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10495-009-0321-2","article-title":"Is TRAIL the holy grail of cancer therapy?","volume":"14","author":"Newsom-Davis","year":"2009","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jhep.2000.16266","article-title":"Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines","volume":"32","author":"Yamanaka","year":"2000","journal-title":"Hepatology"},{"issue":"47","key":"10.1016\/j.biopha.2018.12.004_bib0160","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.3748\/wjg.15.5924","article-title":"TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies","volume":"15","author":"Koehler","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2018.12.004_bib0165","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.186.7.1165","article-title":"Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family","volume":"186","author":"Degli-Esposti","year":"1997","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0170","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1074-7613(00)80399-4","article-title":"The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain","volume":"7","author":"Degli-Esposti","year":"1997","journal-title":"Immunity"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.12.004_bib0175","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1038\/sj.cdd.4401437","article-title":"Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs","volume":"11","author":"Ganten","year":"2004","journal-title":"Cell. Death Differ."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/07357900903095631","article-title":"Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells","volume":"28","author":"Lu","year":"2010","journal-title":"Cancer Invest."},{"issue":"7","key":"10.1016\/j.biopha.2018.12.004_bib0185","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-07-6278","article-title":"Mcl-1: a gateway to TRAIL sensitization","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0190","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ejca.2009.12.025","article-title":"The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms","volume":"46","author":"Llobet","year":"2010","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"issue":"19","key":"10.1016\/j.biopha.2018.12.004_bib0195","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1158\/0008-5472.CAN-07-0598","article-title":"The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation","volume":"67","author":"Rosato","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.21054","article-title":"HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL","volume":"43","author":"Pathil","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0205","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.20807","article-title":"Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL","volume":"42","author":"Ganten","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2018.12.004_bib0210","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1007\/s11033-014-3577-8","article-title":"Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells","volume":"41","author":"Fayyaz","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2018.12.004_bib0215","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/jcb.25910","article-title":"LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway","volume":"118","author":"Liao","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.biopha.2018.12.004_bib0220","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2174\/13894501113149990183","article-title":"Function of miRNA in controlling drug resistance of human cancers","volume":"14","author":"Hong","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0225","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41419-018-0350-2","article-title":"CASC2\/miR-24\/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8\/caspase-3","volume":"9","author":"Jin","year":"2018","journal-title":"Cell. Death Dis."},{"issue":"13","key":"10.1016\/j.biopha.2018.12.004_bib0230","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.7150\/thno.19893","article-title":"Combination of AAV-TRAIL with miR-221-zip therapeutic strategy overcomes the resistance to TRAIL induced apoptosis in liver cancer","volume":"7","author":"Ma","year":"2017","journal-title":"Theranostics"},{"issue":"26","key":"10.1016\/j.biopha.2018.12.004_bib0235","doi-asserted-by":"crossref","first-page":"41921","DOI":"10.18632\/oncotarget.16707","article-title":"MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0240","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3892\/ijo.2016.3751","article-title":"Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN\/PI3K\/Akt\/Bad signaling pathway","volume":"49","author":"Feng","year":"2016","journal-title":"Int. J Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0245","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3892\/or.2016.5278","article-title":"miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer","volume":"37","author":"Huang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/gt.2017.86","article-title":"Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma","volume":"25","author":"Galal El-Shemi","year":"2018","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0255","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep.29513","article-title":"A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0260","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/156652409788167078","article-title":"The TRAIL to viral pathogenesis: the good, the bad and the ugly","volume":"9","author":"Cummins","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biopha.2018.12.004_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0083-6729(04)67014-2","article-title":"TRAIL and viral infection","volume":"67","author":"Strater","year":"2004","journal-title":"Vitam. Horm."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0270","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3748\/wjg.v8.i6.1077","article-title":"Detection of soluble TRAIL in HBV infected patients and its clinical implications","volume":"8","author":"Han","year":"2002","journal-title":"World J. Gastroenterol."},{"issue":"26","key":"10.1016\/j.biopha.2018.12.004_bib0275","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.3748\/wjg.v11.i26.4090","article-title":"Association between TRAIL expression on peripheral blood lymphocytes and liver damage in chronic hepatitis B","volume":"11","author":"Chen","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0280","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinre.2012.09.009","article-title":"Expression of TRAIL in liver tissue from patients with different outcomes of HBV infection","volume":"37","author":"Liu","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0285","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0168-8278(03)00265-4","article-title":"Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1\/death receptor 4 expression","volume":"39","author":"Janssen","year":"2003","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.178.1.503","article-title":"Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax","volume":"178","author":"Liang","year":"2007","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0295","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1096\/fj.02-0537fje","article-title":"Involvement of TRAIL and its receptors in viral hepatitis","volume":"17","author":"Mundt","year":"2003","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.biopha.2018.12.004_bib0300","doi-asserted-by":"crossref","first-page":"e0127329","DOI":"10.1371\/journal.pone.0127329","article-title":"Hepatitis B virus X protein sensitizes TRAIL-induced hepatocyte apoptosis by inhibiting the E3 ubiquitin ligase A20","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/cdd.2008.144","article-title":"Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression","volume":"16","author":"Du","year":"2009","journal-title":"Cell. Death Differ."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0310","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0315","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/JVI.01694-06","article-title":"TRAIL is a novel antiviral protein against dengue virus","volume":"82","author":"Warke","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0320","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2003-06-2137","article-title":"TRAIL regulates normal erythroid maturation through an ERK-dependent pathway","volume":"103","author":"Secchiero","year":"2004","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.biopha.2018.12.004_bib0325","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1128\/MCB.00297-06","article-title":"Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression","volume":"26","author":"Hatzis","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"10.1016\/j.biopha.2018.12.004_bib0330","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1128\/JVI.77.14.7707-7712.2003","article-title":"Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway","volume":"77","author":"Zheng","year":"2003","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jir.2006.26.119","article-title":"Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C","volume":"26","author":"Pelli","year":"2006","journal-title":"J. Interferon Cytokine Res."},{"issue":"10","key":"10.1016\/j.biopha.2018.12.004_bib0340","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.humpath.2005.07.019","article-title":"Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases","volume":"36","author":"Saitou","year":"2005","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.biopha.2018.12.004_bib0345","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.2004.056929","article-title":"Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake","volume":"54","author":"Mundt","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biopha.2018.12.004_bib0350","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.prp.2013.10.005","article-title":"Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection","volume":"210","author":"Brost","year":"2014","journal-title":"Pathol Res. Pract."},{"issue":"5","key":"10.1016\/j.biopha.2018.12.004_bib0355","doi-asserted-by":"crossref","first-page":"e37700","DOI":"10.1371\/journal.pone.0037700","article-title":"Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathway","volume":"7","author":"Deng","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2018.12.004_bib0360","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","article-title":"Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection","volume":"138","author":"Stegmann","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2018.12.004_bib0365","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2017.07.028","article-title":"Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56(bright) NK cells","volume":"67","author":"Mele","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2018.12.004_bib0370","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/bc200187k","article-title":"PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects","volume":"22","author":"Kim","year":"2011","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2018.12.004_bib0375","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00251-009-0389-4","article-title":"sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease","volume":"61","author":"Yan","year":"2009","journal-title":"Immunogenetics"},{"key":"10.1016\/j.biopha.2018.12.004_bib0380","first-page":"Cd011640","article-title":"Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis","volume":"3","author":"Lombardi","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0385","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hep.28520","article-title":"Paving the TRAIL to anti-fibrotic therapy","volume":"64","author":"Guicciardi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.004_bib0390","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","article-title":"Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression","volume":"24","author":"Farrell","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0395","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41598-017-01721-4","article-title":"Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice","volume":"7","author":"Cartland","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2018.12.004_bib0400","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep4.1069","article-title":"TRAIL deletion prevents liver, but not adipose tissue, inflammation during murine diet-induced obesity","volume":"1","author":"Hirsova","year":"2017","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/CS20171221","article-title":"TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse","volume":"132","author":"Bernardi","year":"2018","journal-title":"Clin. Sci. (Lond., Engl.: 1979)"},{"issue":"7","key":"10.1016\/j.biopha.2018.12.004_bib0410","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.191.7.1095","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression","volume":"191","author":"Song","year":"2000","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0415","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10238-009-0052-2","article-title":"Resistance to activation-induced cell death and elevated FLIPL expression of CD4+ T cells in a polyI:C-induced primary biliary cirrhosis mouse model","volume":"9","author":"Jiang","year":"2009","journal-title":"Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.004_bib0420","first-page":"360","article-title":"Receptor-specific TRAIL as a means to achieve targeted elimination of activated hepatic stellate cells","volume":"25","author":"Rombouts","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2018.12.004_bib0425","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cellsig.2009.05.008","article-title":"Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells","volume":"21","author":"Park","year":"2009","journal-title":"Cell Signal."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0430","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jhep.2003.50002","article-title":"Activated stellate cells express the TRAIL receptor-2\/death receptor-5 and undergo TRAIL-mediated apoptosis","volume":"37","author":"Taimr","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.12.004_bib0435","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.intimp.2016.01.013","article-title":"Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL","volume":"32","author":"Xu","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2018.12.004_bib0440","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jgm.2776","article-title":"Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL)","volume":"16","author":"Arabpour","year":"2014","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2018.12.004_bib0445","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3389\/fphar.2017.00980","article-title":"MicroRNA-145 increases the apoptosis of activated hepatic stellate cells induced by TRAIL through NF-kappaB signaling pathway","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.004_bib0450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.28432","article-title":"Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells","volume":"64","author":"Oh","year":"2016","journal-title":"Hepatology"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218363893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218363893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:23:36Z","timestamp":1764105816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218363893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":90,"alternative-id":["S0753332218363893"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.004","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into the role of TRAIL in liver diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}